{"entities":[{"id":"alphafold-account","name":"AlphaFold — CASP14 research account (2020)","type":"document"},{"id":"aib-doc-esm3-release-2024","name":"ESM3: Simulating 500 million years of evolution with a language model","type":"document"},{"id":"aib-doc-exscientia-prospectus-2021","name":"Exscientia plc IPO prospectus (424B4)","type":"document"},{"id":"aib-doc-insilico-rentosertib-ph3-initiation-2026","name":"Insilico Medicine: Initiation of Rentosertib Phase III Clinical Trial","type":"document"},{"id":"aib-doc-iso-launch-2021","name":"Introducing Isomorphic Labs","type":"document"},{"id":"aib-doc-rfdiffusion-2023","name":"De novo design of protein structure and function with RFdiffusion","type":"document"},{"id":"aib-doc-ahlmann-eltze-2025","name":"Deep-learning-based gene perturbation effect prediction does not yet outperform simple linear baselines","type":"document"},{"id":"aib-doc-arnold-2023","name":"AlphaFold touted as next big thing for drug discovery — but is it?","type":"document"},{"id":"aib-doc-berg-bpm31510-2013","name":"Berg Launches First-Ever Stratified Medicine Clinical Trial To Investigate Cancer Metabolism Of Solid Tumors","type":"document"},{"id":"aib-doc-blundell-1987","name":"Knowledge-based prediction of protein structures and the design of novel molecules","type":"document"},{"id":"aib-doc-bray-1990","name":"Intracellular signalling as a parallel distributed process","type":"document"},{"id":"aib-doc-bunne-2024","name":"How to Build the Virtual Cell with Artificial Intelligence: Priorities and Opportunities","type":"document"},{"id":"aib-doc-hallucination-preprint-2020","name":"De novo protein design by deep network hallucination","type":"document"},{"id":"aib-doc-hood-galas-2003","name":"The digital code of DNA","type":"document"},{"id":"aib-doc-huang-2016","name":"The coming of age of de novo protein design","type":"document"},{"id":"aib-doc-jayatunga-2024","name":"How successful are AI-discovered drugs in clinical trials? A first analysis and emerging lessons","type":"document"},{"id":"aib-doc-lyu-2024","name":"AlphaFold2 structures guide prospective ligand discovery","type":"document"},{"id":"aib-doc-ma-2018","name":"Using deep learning to model the hierarchical structure and function of a cell","type":"document"},{"id":"aib-doc-mullard-2021","name":"What does AlphaFold mean for drug discovery?","type":"document"},{"id":"aib-doc-roohani-2025","name":"Virtual Cell Challenge: Toward a Turing test for the virtual cell","type":"document"},{"id":"aib-doc-sternberg-1992","name":"Modelling the structure and function of enzymes by machine learning","type":"document"},{"id":"aib-doc-sumitomo-dsp1181-2020","name":"Sumitomo Dainippon Pharma and Exscientia Joint Development New Drug Candidate Created Using Artificial Intelligence (AI) Begins Clinical Study","type":"document"},{"id":"aib-doc-terwilliger-2023","name":"AlphaFold predictions are valuable hypotheses and accelerate but do not replace experimental structure determination","type":"document"},{"id":"aib-doc-tomita-2001","name":"Whole-cell simulation: a grand challenge of the 21st century","type":"document"},{"id":"aib-doc-wang-2018","name":"Computational Protein Design with Deep Learning Neural Networks","type":"document"},{"id":"aib-doc-wong-2022","name":"Benchmarking AlphaFold-enabled molecular docking predictions for antibiotic discovery","type":"document"},{"id":"aib-doc-xu-2025","name":"A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial","type":"document"},{"id":"aib-prop-ai-drug-candidate-in-trials","name":"A drug candidate discovered or designed with AI has entered human clinical trials","type":"concept","proposition":{"code":"P3","criterion":"The text states that a named drug candidate, described as discovered, designed or created using AI, has begun testing in humans in a clinical trial.","terms":[]}},{"id":"aib-prop-ai-drugs-higher-trial-success","name":"AI-discovered drug candidates succeed in clinical trials more often than historical averages","type":"concept","proposition":{"code":"P6","criterion":"The text states that drug candidates discovered or designed with AI have passed at least one phase of clinical trials at a higher rate than historical industry averages.","terms":[]}},{"id":"aib-prop-ai-virtual-cell","name":"AI models can simulate or predict the behaviour of cells (a \"virtual cell\")","type":"concept","proposition":{"code":"P2","criterion":"The text states that a machine-learning or other AI model simulates, or will be able to simulate or predict, the behaviour of a living cell, such as its growth or its responses to perturbations.","terms":["virtual cell","AI Virtual Cell"]}},{"id":"aib-prop-biology-as-information-for-ai","name":"Biology is an information system that AI can read, describe or program","type":"concept","proposition":{"code":"P5","criterion":"The text states that biology is, or can be treated as, an information system, language or code, and that AI is, or may become, the means of reading, describing or programming it.","terms":["digital biology","programmable biology"],"withheld":[{"role":"earliest-located","reason":"Withheld until the criterion is decided (maintainer decision of 2026-10-30). The cross-family check located an earlier candidate, Searls (AAAI-88 proceedings, 1988), which treats genetic information as a knowledge representation for symbolic AI. Whether that meets the criterion’s AI clause is unsettled.","recordedAt":"2026-10-31"}]}},{"id":"aib-prop-ml-designs-new-proteins","name":"Machine-learning methods make proteins with new functions designable","type":"concept","proposition":{"code":"P4","criterion":"The text states that machine-learning models can be used, or will contribute, to designing proteins with functions, or sequences, not found among natural proteins.","terms":[],"withheld":[{"role":"earliest-located","reason":"Withheld until the criterion is decided (maintainer decision of 2026-10-30). The cross-family check located earlier candidates, Schneider and Wrede (1994) on sequence design assisted by neural networks and Greener, Moffat and Jones (arXiv, 26 June 2018) on sequences for a novel protein topology. Whether either meets the criterion’s “not found among natural proteins” is unsettled.","recordedAt":"2026-10-31"}]}},{"id":"aib-prop-predicted-structures-aid-drug-design","name":"Predicted protein structures aid drug design","type":"concept","proposition":{"code":"P1","criterion":"The text states that protein structures obtained by computational prediction, rather than by experiment, are or will be of use in designing or discovering drugs.","terms":["structure-based drug design"]}}],"claims":[{"id":"aib-arg-p1-blundell-1987","subject":"aib-doc-blundell-1987","predicate":"articulates_proposition","object":{"kind":"entity","entityId":"aib-prop-predicted-structures-aid-drug-design"},"topic":"ideas","time":{"kind":"event","date":"1987-03-26","basis":"publication","note":"Publication and issue date printed on the Nature article page."},"attributes":{"thought":{"roles":["earliest-located"],"register":"nonfiction","qualifier":"Stated of knowledge-based (comparative) modelling, as a field of use; no drug is named."}}},{"id":"aib-arg-p1-sternberg-1992","subject":"aib-doc-sternberg-1992","predicate":"bears_on_proposition","object":{"kind":"entity","entityId":"aib-prop-predicted-structures-aid-drug-design"},"topic":"ideas","time":{"kind":"event","date":"1992","basis":"publication","note":"Year of the Faraday Discussions issue (vol. 93) as given by Europe PMC; no finer date was retrieved."},"attributes":{"thought":{"roles":["context"],"register":"nonfiction","missing":"Does not state that predicted protein structures aid drug design: the structure-prediction and drug-design applications are separate, and the drug-design model rests on ligand activities, not on a predicted protein structure."}}},{"id":"aib-arg-p2-tomita-2001","subject":"aib-doc-tomita-2001","predicate":"bears_on_proposition","object":{"kind":"entity","entityId":"aib-prop-ai-virtual-cell"},"topic":"ideas","time":{"kind":"event","date":"2001-06","basis":"publication","note":"Issue month as given by Europe PMC."},"attributes":{"thought":{"roles":["context","earliest-located-term"],"register":"nonfiction","term":"virtual cell","missing":"No AI or machine-learning element: the virtual cell is a computer simulation built from biological data."}}},{"id":"aib-arg-p5-hood-galas-2003","subject":"aib-doc-hood-galas-2003","predicate":"bears_on_proposition","object":{"kind":"entity","entityId":"aib-prop-biology-as-information-for-ai"},"topic":"ideas","time":{"kind":"event","date":"2003-01-23","basis":"publication","note":"Publication date printed on the article page."},"attributes":{"thought":{"roles":["context"],"register":"nonfiction","missing":"No AI element: the information view is tied to DNA and genomics, not to AI as the means of reading or describing biology."}}},{"id":"aib-arg-p4-huang-2016","subject":"aib-doc-huang-2016","predicate":"bears_on_proposition","object":{"kind":"entity","entityId":"aib-prop-ml-designs-new-proteins"},"topic":"ideas","time":{"kind":"event","date":"2016-09-14","basis":"publication","note":"Online publication date printed on the article page."},"attributes":{"thought":{"roles":["context"],"register":"nonfiction","missing":"No machine-learning element: the design methods are physics-based."}}},{"id":"aib-arg-p2-ma-2018","subject":"aib-doc-ma-2018","predicate":"articulates_proposition","object":{"kind":"entity","entityId":"aib-prop-ai-virtual-cell"},"topic":"ideas","time":{"kind":"event","date":"2018-03-05","basis":"publication","note":"Online publication date printed on the article page."},"attributes":{"thought":{"roles":["articulation"],"register":"nonfiction","qualifier":"Stated of growth prediction from genotype in one eukaryotic cell model."}}},{"id":"aib-arg-p4-wang-2018","subject":"aib-doc-wang-2018","predicate":"bears_on_proposition","object":{"kind":"entity","entityId":"aib-prop-ml-designs-new-proteins"},"topic":"ideas","time":{"kind":"event","date":"2018-04-20","basis":"publication","note":"Publication date printed on the article page."},"attributes":{"thought":{"roles":["context"],"register":"nonfiction","missing":"Applies machine learning to protein design but does not state that it makes proteins with new functions or unnatural sequences designable."}}},{"id":"aib-arg-p3-sumitomo-2020","subject":"aib-doc-sumitomo-dsp1181-2020","predicate":"articulates_proposition","object":{"kind":"entity","entityId":"aib-prop-ai-drug-candidate-in-trials"},"topic":"ideas","time":{"kind":"event","date":"2020-01-30","basis":"announcement","note":"Date printed on the release."},"attributes":{"thought":{"roles":["articulation"],"register":"nonfiction","qualifier":"A company announcement of a phase I study start."}}},{"id":"aib-arg-p4-anishchenko-2020","subject":"aib-doc-hallucination-preprint-2020","predicate":"articulates_proposition","object":{"kind":"entity","entityId":"aib-prop-ml-designs-new-proteins"},"topic":"ideas","time":{"kind":"event","date":"2020-07-23","basis":"publication","note":"Date of bioRxiv v1, from the bioRxiv details API. The journal version (Nature, published online 1 December 2021) carries the same concluding statement in edited wording."},"attributes":{"thought":{"roles":["articulation"],"register":"nonfiction","qualifier":"An expectation for new functions, from a demonstration of new folded proteins."}}},{"id":"aib-arg-p1-deepmind-2020","subject":"alphafold-account","predicate":"articulates_proposition","object":{"kind":"entity","entityId":"aib-prop-predicted-structures-aid-drug-design"},"topic":"ideas","time":{"kind":"event","date":"2020-11-30","basis":"publication","note":"Date printed on the page. The quotations are those of the copy served on 2026-10-30, which carries a July 2022 update notice at its head; the cross-family check of 2026-10-30 found the passage and the header date of 30 November 2020 in the Internet Archive capture of 2 December 2020, recorded as a source of its own."},"attributes":{"thought":{"roles":["articulation"],"register":"nonfiction","qualifier":"A possibility, framed as complementing experimental methods."}}},{"id":"aib-arg-p1-mullard-2021","subject":"aib-doc-mullard-2021","predicate":"bears_on_proposition","object":{"kind":"entity","entityId":"aib-prop-predicted-structures-aid-drug-design"},"topic":"ideas","time":{"kind":"event","date":"2021-09-14","basis":"publication","note":"Date printed on the article page."},"attributes":{"thought":{"roles":["context"],"register":"nonfiction","missing":"Assesses the degree of the implications for drug discovery (\"more incremental\"); it does not state that predicted structures are of no use, nor that they are of use."}}},{"id":"aib-arg-p3-exscientia-2021","subject":"aib-doc-exscientia-prospectus-2021","predicate":"articulates_proposition","object":{"kind":"entity","entityId":"aib-prop-ai-drug-candidate-in-trials"},"topic":"ideas","time":{"kind":"event","date":"2021-09-30","basis":"publication","note":"Dated by the prospectus; the trial start month (December 2020) is the company's statement within it."},"attributes":{"thought":{"roles":["articulation"],"register":"nonfiction","qualifier":"A prospectus statement by the issuer; the priority wording is the company’s and is quoted, not adopted."}}},{"id":"aib-arg-p5-isomorphic-2021","subject":"aib-doc-iso-launch-2021","predicate":"articulates_proposition","object":{"kind":"entity","entityId":"aib-prop-biology-as-information-for-ai"},"topic":"ideas","time":{"kind":"event","date":"2021-11","basis":"publication","note":"Month of the launch article as its original-period capture displays it (cross-family check of 2026-10-30); the page as served in 2026 displays 1 November 2021, a day no contemporaneous expression confirms."},"attributes":{"thought":{"roles":["articulation"],"register":"nonfiction","qualifier":"Stated as a personal view (\"I think\") and a possibility (\"may\").","attested":{"date":"2026-10-30","note":"The quoted wording is attested in the page as served on 30 October 2026. The capture of November 2021 was read by the cross-family check for its date and opening, not for this passage, and differs from the later page in at least one phrase."}}}},{"id":"aib-arg-p1-wong-2022","subject":"aib-doc-wong-2022","predicate":"bears_on_proposition","object":{"kind":"entity","entityId":"aib-prop-predicted-structures-aid-drug-design"},"topic":"ideas","time":{"kind":"event","date":"2022-09-06","basis":"publication","note":"Online publication date from the JATS history of the Europe PMC full text."},"attributes":{"thought":{"roles":["context"],"register":"nonfiction","missing":"A caution about present docking methods; it neither states nor disputes that predicted structures aid drug discovery, and it frames AlphaFold2 as something to be \"better harnessed\"."}}},{"id":"aib-arg-p4-watson-2023","subject":"aib-doc-rfdiffusion-2023","predicate":"articulates_proposition","object":{"kind":"entity","entityId":"aib-prop-ml-designs-new-proteins"},"topic":"ideas","time":{"kind":"event","date":"2023-07-11","basis":"publication","note":"Online publication date printed on the article page."},"attributes":{"thought":{"roles":["articulation"],"register":"nonfiction","qualifier":"Stated of the authors' own method."}}},{"id":"aib-arg-p1-arnold-2023","subject":"aib-doc-arnold-2023","predicate":"bears_on_proposition","object":{"kind":"entity","entityId":"aib-prop-predicted-structures-aid-drug-design"},"topic":"ideas","time":{"kind":"event","date":"2023-09-22","basis":"publication","note":"Date printed on the article page."},"attributes":{"thought":{"roles":["context"],"register":"nonfiction","missing":"Reports an open question about degree (whether AlphaFold can \"really shake up\" the industry); the readable text neither states nor disputes the criterion."}}},{"id":"aib-arg-p1-terwilliger-2023","subject":"aib-doc-terwilliger-2023","predicate":"bears_on_proposition","object":{"kind":"entity","entityId":"aib-prop-predicted-structures-aid-drug-design"},"topic":"ideas","time":{"kind":"event","date":"2023-11-30","basis":"publication","note":"Online publication date printed on the article page."},"attributes":{"thought":{"roles":["context"],"register":"nonfiction","missing":"Addresses whether predictions can substitute for experimental structures, not whether they aid drug design."}}},{"id":"aib-arg-p3-jayatunga-2024","subject":"aib-doc-jayatunga-2024","predicate":"bears_on_proposition","object":{"kind":"entity","entityId":"aib-prop-ai-drug-candidate-in-trials"},"topic":"ideas","time":{"kind":"event","date":"2024-04-30","basis":"publication","note":"Electronic publication date as given by Europe PMC."},"attributes":{"thought":{"roles":["context"],"register":"nonfiction","missing":"Names no specific candidate in the abstract read; the criterion requires a named candidate stated to have begun human testing."}}},{"id":"aib-arg-p6-jayatunga-2024","subject":"aib-doc-jayatunga-2024","predicate":"articulates_proposition","object":{"kind":"entity","entityId":"aib-prop-ai-drugs-higher-trial-success"},"topic":"ideas","time":{"kind":"event","date":"2024-04-30","basis":"publication","note":"Electronic publication date as given by Europe PMC."},"attributes":{"thought":{"roles":["earliest-located"],"register":"nonfiction","qualifier":"Phase I only; phase II stated as comparable."}}},{"id":"aib-arg-p1-lyu-2024","subject":"aib-doc-lyu-2024","predicate":"articulates_proposition","object":{"kind":"entity","entityId":"aib-prop-predicted-structures-aid-drug-design"},"topic":"ideas","time":{"kind":"event","date":"2024-05-16","basis":"publication","note":"Online publication date on the publisher’s page, in its capture of 16 May 2024 read by the cross-family machine check of 2026-10-30; the print issue is dated 21 June 2024, which the Europe PMC record quoted here labels as the date of electronic publication. The disagreement is kept."},"attributes":{"thought":{"roles":["articulation","earliest-located-term"],"register":"nonfiction","term":"structure-based drug design","qualifier":"Stated for two receptors, from prospective docking results reported by the authors."}}},{"id":"aib-arg-p4-esm3-2024","subject":"aib-doc-esm3-release-2024","predicate":"articulates_proposition","object":{"kind":"entity","entityId":"aib-prop-ml-designs-new-proteins"},"topic":"ideas","time":{"kind":"event","date":"2024-06-25","basis":"announcement","note":"Date printed on the post; the wording is attested in the copy served on 2026-10-30, which carries a January 2025 update notice."},"attributes":{"thought":{"roles":["articulation"],"register":"nonfiction","qualifier":"A company's statement of a sequence distant from known natural proteins with a known (fluorescent) function."}}},{"id":"aib-arg-p5-esm3-2024","subject":"aib-doc-esm3-release-2024","predicate":"articulates_proposition","object":{"kind":"entity","entityId":"aib-prop-biology-as-information-for-ai"},"topic":"ideas","time":{"kind":"event","date":"2024-06-25","basis":"announcement","note":"Date printed on the post; the wording is attested in the copy served on 2026-10-30."},"attributes":{"thought":{"roles":["articulation"],"register":"nonfiction","qualifier":"Conditional, in a company's announcement of its own model."}}},{"id":"aib-arg-p2-bunne-2024","subject":"aib-doc-bunne-2024","predicate":"articulates_proposition","object":{"kind":"entity","entityId":"aib-prop-ai-virtual-cell"},"topic":"ideas","time":{"kind":"event","date":"2024-09-18","basis":"publication","note":"Date of the arXiv v1 submission, the expression read."},"attributes":{"thought":{"roles":["articulation"],"register":"nonfiction","qualifier":"A proposal and research agenda, in the future tense."}}},{"id":"aib-arg-p3-xu-2025","subject":"aib-doc-xu-2025","predicate":"articulates_proposition","object":{"kind":"entity","entityId":"aib-prop-ai-drug-candidate-in-trials"},"topic":"ideas","time":{"kind":"event","date":"2025-06-03","basis":"publication","note":"Online publication date printed on the article page."},"attributes":{"thought":{"roles":["articulation"],"register":"nonfiction","qualifier":"A sponsor-authored trial report; the phase is as stated (2a)."}}},{"id":"aib-arg-p6-xu-2025","subject":"aib-doc-xu-2025","predicate":"bears_on_proposition","object":{"kind":"entity","entityId":"aib-prop-ai-drugs-higher-trial-success"},"topic":"ideas","time":{"kind":"event","date":"2025-06-03","basis":"publication","note":"Online publication date printed on the article page."},"attributes":{"thought":{"roles":["context"],"register":"nonfiction","missing":"Addresses phases 2 and 3 only; it neither states nor disputes a higher success rate in phase I."}}},{"id":"aib-arg-p2-roohani-2025","subject":"aib-doc-roohani-2025","predicate":"articulates_proposition","object":{"kind":"entity","entityId":"aib-prop-ai-virtual-cell"},"topic":"ideas","time":{"kind":"event","date":"2025-06","basis":"publication","note":"Issue month as given by Europe PMC."},"attributes":{"thought":{"roles":["articulation"],"register":"nonfiction","qualifier":"States the goal and a benchmark for it; does not claim the goal is met."}}},{"id":"aib-arg-p2-ahlmann-eltze-2025","subject":"aib-doc-ahlmann-eltze-2025","predicate":"contests_proposition","object":{"kind":"entity","entityId":"aib-prop-ai-virtual-cell"},"topic":"ideas","time":{"kind":"event","date":"2025-08-04","basis":"publication","note":"Online publication date printed on the article page."},"attributes":{"thought":{"roles":["contesting"],"register":"nonfiction","qualifier":"Challenges the present performance of the tested models; not a contradiction of the proposition as a whole."}}},{"id":"aib-arg-p3-insilico-2026","subject":"aib-doc-insilico-rentosertib-ph3-initiation-2026","predicate":"articulates_proposition","object":{"kind":"entity","entityId":"aib-prop-ai-drug-candidate-in-trials"},"topic":"ideas","time":{"kind":"event","date":"2026-07-08","basis":"announcement","note":"Date of the HKEXnews listing of the announcement."},"attributes":{"thought":{"roles":["articulation"],"register":"nonfiction","qualifier":"A company announcement to the Hong Kong exchange; the phase is as stated."}}},{"id":"aib-arg-p2-bray-1990","subject":"aib-doc-bray-1990","predicate":"articulates_proposition","object":{"kind":"entity","entityId":"aib-prop-ai-virtual-cell"},"topic":"ideas","time":{"kind":"event","date":"1990-03-22","basis":"publication","note":"Date of the journal issue in the PubMed citation (J Theor Biol 1990 Mar 22;143(2):215–231)."},"attributes":{"thought":{"roles":["earliest-located"],"register":"nonfiction","qualifier":"A proposed network model of a signalling pathway, not of a whole cell."}}},{"id":"aib-arg-p3-berg-2013","subject":"aib-doc-berg-bpm31510-2013","predicate":"articulates_proposition","object":{"kind":"entity","entityId":"aib-prop-ai-drug-candidate-in-trials"},"topic":"ideas","time":{"kind":"event","date":"2013-11-21","basis":"announcement","note":"Date of the release (“Nov 21, 2013, 09:29 ET”); the announcement date is not the trial’s start date."},"attributes":{"thought":{"roles":["earliest-located"],"register":"nonfiction","qualifier":"A company announcement of a trial, with the company’s account of how the compound was found."}}}],"sources":[{"id":"source-atlas-alphafold-account","authors":["DeepMind"],"publisherId":"deepmind"},{"id":"source-aib-watson-2023-nature","documentId":"aib-doc-rfdiffusion-2023","authors":["Joseph L. Watson","David Juergens","Nathaniel R. Bennett","Brian L. Trippe","Jason Yim","Helen E. Eisenach","Woody Ahern","Andrew J. Borst","Robert J. Ragotte","Lukas F. Milles","Basile I. M. Wicky","Nikita Hanikel","Samuel J. Pellock","Alexis Courbet","William Sheffler","Jue Wang","Preetham Venkatesh","Isaac Sappington","Susana Vázquez Torres","Anna Lauko","Valentin De Bortoli","Emile Mathieu","Sergey Ovchinnikov","Regina Barzilay","Tommi S. Jaakkola","Frank DiMaio","Minkyung Baek","David Baker"]},{"id":"source-aib-companies-insilico-ph3-init","documentId":"aib-doc-insilico-rentosertib-ph3-initiation-2026","authors":["InSilico Medicine Cayman TopCo, published on HKEXnews"]},{"id":"source-aib-companies-exs-424b4","documentId":"aib-doc-exscientia-prospectus-2021","authors":["Exscientia plc (filed with the US SEC)"],"publisherId":"aib-exscientia"},{"id":"source-aib-labs-iso-launch","documentId":"aib-doc-iso-launch-2021","authors":["Isomorphic Labs"],"publisherId":"aib-isomorphic-labs"},{"id":"source-aib-esm3-release-post","documentId":"aib-doc-esm3-release-2024","authors":["EvolutionaryScale"],"publisherId":"aib-evolutionaryscale"},{"id":"source-aib-blundell-1987-nature","documentId":"aib-doc-blundell-1987","authors":["T. L. Blundell","B. L. Sibanda","M. J. E. Sternberg","J. M. Thornton"]},{"id":"source-aib-sternberg-1992-epmc","documentId":"aib-doc-sternberg-1992","authors":["Sternberg MJ","Lewis RA","King RD","Muggleton S"]},{"id":"source-aib-mullard-2021-nrdd","documentId":"aib-doc-mullard-2021","authors":["Asher Mullard"]},{"id":"source-aib-wong-2022-msb","documentId":"aib-doc-wong-2022","authors":["Wong F","Krishnan A","Zheng EJ","Stärk H","Manson AL","Earl AM","Jaakkola T","Collins JJ"]},{"id":"source-aib-terwilliger-2023-natmethods","documentId":"aib-doc-terwilliger-2023","authors":["Thomas C. Terwilliger","Dorothee Liebschner","Tristan I. Croll"]},{"id":"source-aib-arnold-2023-nature-news","documentId":"aib-doc-arnold-2023","authors":["Carrie Arnold"]},{"id":"source-aib-lyu-2024-epmc","documentId":"aib-doc-lyu-2024","authors":["Lyu J","Kapolka N","Gumpper R","Shoichet BK","Roth BL"]},{"id":"source-aib-tomita-2001-epmc","documentId":"aib-doc-tomita-2001","authors":["Tomita M"]},{"id":"source-aib-ma-2018-natmethods","documentId":"aib-doc-ma-2018","authors":["Jianzhu Ma","Michael Ku Yu","Samson Fong","Keiichiro Ono","Eric Sage","Barry Demchak","Roded Sharan","Trey Ideker"]},{"id":"source-aib-bunne-2024-arxiv","documentId":"aib-doc-bunne-2024","authors":["Charlotte Bunne","Yusuf Roohani","Yanay Rosen","Stephen R. Quake"],"publisherId":"arxiv"},{"id":"source-aib-roohani-2025-epmc","documentId":"aib-doc-roohani-2025","authors":["Roohani YH","Hua TJ","Tung PY","Hsu PD","Goodarzi H","Burke DP"]},{"id":"source-aib-ahlmann-eltze-2025-natmethods","documentId":"aib-doc-ahlmann-eltze-2025","authors":["Constantin Ahlmann-Eltze","Wolfgang Huber","Simon Anders"]},{"id":"source-aib-sumitomo-exscientia-2020","documentId":"aib-doc-sumitomo-dsp1181-2020","authors":["Sumitomo Pharma (then Sumitomo Dainippon Pharma)"]},{"id":"source-aib-xu-2025-natmed","documentId":"aib-doc-xu-2025","authors":["Zuojun Xu","Feng Ren","Ping Wang","Alex Zhavoronkov"]},{"id":"source-aib-jayatunga-2024-epmc","documentId":"aib-doc-jayatunga-2024","authors":["Kp Jayatunga M","Ayers M","Bruens L","Jayanth D","Meier C"]},{"id":"source-aib-huang-2016-nature","documentId":"aib-doc-huang-2016","authors":["Po-Ssu Huang","Scott E. Boyken","David Baker"]},{"id":"source-aib-wang-2018-srep","documentId":"aib-doc-wang-2018","authors":["Jingxue Wang","Huali Cao","John Z. H. Zhang","Yifei Qi"]},{"id":"source-aib-anishchenko-2020-biorxiv-api","documentId":"aib-doc-hallucination-preprint-2020","authors":["Anishchenko I","Chidyausiku TM","Ovchinnikov S","Pellock SJ","Baker D"]},{"id":"source-aib-hood-galas-2003-nature","documentId":"aib-doc-hood-galas-2003","authors":["Leroy Hood","David Galas"]},{"id":"source-aib-bray-1990-pubmed","documentId":"aib-doc-bray-1990","authors":["D. Bray"]},{"id":"source-aib-berg-2013-prnewswire","documentId":"aib-doc-berg-bpm31510-2013","authors":["Berg"]}],"evidence":[],"at":{"entities":[133,1344,1347,1355,1358,1365,1411,1412,1413,1414,1415,1416,1417,1418,1419,1420,1421,1422,1423,1424,1425,1426,1427,1428,1429,1430,1431,1437,1438,1439,1440,1441,1442],"claims":[3716,3717,3718,3719,3720,3721,3722,3723,3724,3725,3726,3727,3728,3729,3730,3731,3732,3733,3734,3735,3736,3737,3738,3739,3740,3741,3742,3743,3744,3745],"sources":[133,1137,1153,1156,1157,1192,1210,1211,1212,1213,1214,1215,1216,1217,1218,1219,1220,1221,1222,1223,1224,1225,1226,1227,1229,1237,1238],"evidence":[]},"index":{"byClaim":[["aib-arg-p1-blundell-1987",["propositions:ai-in-science"]],["aib-arg-p1-sternberg-1992",["propositions:ai-in-science"]],["aib-arg-p1-deepmind-2020",["propositions:ai-in-science"]],["aib-arg-p1-mullard-2021",["propositions:ai-in-science"]],["aib-arg-p1-wong-2022",["propositions:ai-in-science"]],["aib-arg-p1-arnold-2023",["propositions:ai-in-science"]],["aib-arg-p1-terwilliger-2023",["propositions:ai-in-science"]],["aib-arg-p1-lyu-2024",["propositions:ai-in-science"]],["aib-arg-p2-bray-1990",["propositions:ai-in-science"]],["aib-arg-p2-tomita-2001",["propositions:ai-in-science"]],["aib-arg-p2-ma-2018",["propositions:ai-in-science"]],["aib-arg-p2-bunne-2024",["propositions:ai-in-science"]],["aib-arg-p2-roohani-2025",["propositions:ai-in-science"]],["aib-arg-p2-ahlmann-eltze-2025",["propositions:ai-in-science"]],["aib-arg-p3-berg-2013",["propositions:ai-in-science"]],["aib-arg-p3-sumitomo-2020",["propositions:ai-in-science"]],["aib-arg-p3-exscientia-2021",["propositions:ai-in-science"]],["aib-arg-p3-jayatunga-2024",["propositions:ai-in-science"]],["aib-arg-p3-xu-2025",["propositions:ai-in-science"]],["aib-arg-p3-insilico-2026",["propositions:ai-in-science"]],["aib-arg-p6-jayatunga-2024",["propositions:ai-in-science"]],["aib-arg-p6-xu-2025",["propositions:ai-in-science"]],["aib-arg-p4-huang-2016",["propositions:ai-in-science"]],["aib-arg-p4-wang-2018",["propositions:ai-in-science"]],["aib-arg-p4-anishchenko-2020",["propositions:ai-in-science"]],["aib-arg-p4-watson-2023",["propositions:ai-in-science"]],["aib-arg-p4-esm3-2024",["propositions:ai-in-science"]],["aib-arg-p5-hood-galas-2003",["propositions:ai-in-science"]],["aib-arg-p5-isomorphic-2021",["propositions:ai-in-science"]],["aib-arg-p5-esm3-2024",["propositions:ai-in-science"]]],"marks":[["aib-doc-berg-bpm31510-2013",[{"collectionId":"ai-in-science","propositionId":"aib-prop-ai-drug-candidate-in-trials","claimId":"aib-arg-p3-berg-2013","text":"Earliest located in AI in science for P3 A drug candidate discovered or designed with AI has entered human clinical trials"}]],["aib-doc-blundell-1987",[{"collectionId":"ai-in-science","propositionId":"aib-prop-predicted-structures-aid-drug-design","claimId":"aib-arg-p1-blundell-1987","text":"Earliest located in AI in science for P1 Predicted protein structures aid drug design"}]],["aib-doc-bray-1990",[{"collectionId":"ai-in-science","propositionId":"aib-prop-ai-virtual-cell","claimId":"aib-arg-p2-bray-1990","text":"Earliest located in AI in science for P2 AI models can simulate or predict the behaviour of cells (a \"virtual cell\")"}]],["aib-doc-jayatunga-2024",[{"collectionId":"ai-in-science","propositionId":"aib-prop-ai-drugs-higher-trial-success","claimId":"aib-arg-p6-jayatunga-2024","text":"Earliest located in AI in science for P6 AI-discovered drug candidates succeed in clinical trials more often than historical averages"}]],["aib-doc-lyu-2024",[{"collectionId":"ai-in-science","propositionId":"aib-prop-predicted-structures-aid-drug-design","claimId":"aib-arg-p1-lyu-2024","text":"Earliest located use of the name “structure-based drug design” in AI in science for P1 Predicted protein structures aid drug design"}]],["aib-doc-tomita-2001",[{"collectionId":"ai-in-science","propositionId":"aib-prop-ai-virtual-cell","claimId":"aib-arg-p2-tomita-2001","text":"Earliest located use of the name “virtual cell” in AI in science for P2 AI models can simulate or predict the behaviour of cells (a \"virtual cell\")"}]]],"chronicle":{"years":[{"year":1863,"topics":{"ideas":5},"stated":0},{"year":1865,"topics":{"ideas":1},"stated":0},{"year":1872,"topics":{"ideas":7},"stated":0},{"year":1943,"topics":{"ideas":1},"stated":0},{"year":1947,"topics":{"ideas":2},"stated":0},{"year":1950,"topics":{"ideas":7},"stated":0},{"year":1951,"topics":{"ideas":5},"stated":0},{"year":1952,"topics":{"ideas":2},"stated":0},{"year":1955,"topics":{"ideas":31},"stated":0},{"year":1956,"topics":{"ideas":1},"stated":0},{"year":1957,"topics":{"ideas":1},"stated":0},{"year":1958,"topics":{"ideas":3},"stated":0},{"year":1959,"topics":{"ideas":6},"stated":0},{"year":1960,"topics":{"ideas":11},"stated":0},{"year":1961,"topics":{"ideas":10},"stated":0},{"year":1965,"topics":{"ideas":8},"stated":0},{"year":1966,"topics":{"ideas":20},"stated":0},{"year":1968,"topics":{"ideas":5},"stated":0},{"year":1969,"topics":{"ideas":2},"stated":0},{"year":1971,"topics":{"ideas":4},"stated":0},{"year":1972,"topics":{"ideas":1},"stated":0},{"year":1973,"topics":{"ideas":2},"stated":0},{"year":1974,"topics":{"ideas":2},"stated":0},{"year":1975,"topics":{"ideas":1},"stated":0},{"year":1976,"topics":{"ideas":1},"stated":0},{"year":1977,"topics":{"people":2,"ideas":8},"stated":0},{"year":1979,"topics":{"ideas":10},"stated":0},{"year":1980,"topics":{"ideas":2},"stated":0},{"year":1981,"topics":{"people":2},"stated":0},{"year":1982,"topics":{"ideas":4},"stated":0},{"year":1983,"topics":{"ideas":4},"stated":0},{"year":1984,"topics":{"ideas":21},"stated":0},{"year":1985,"topics":{"ideas":9},"stated":0},{"year":1986,"topics":{"ideas":18},"stated":0},{"year":1987,"topics":{"ideas":1},"stated":0},{"year":1988,"topics":{"ideas":6},"stated":0},{"year":1989,"topics":{"ideas":25},"stated":0},{"year":1990,"topics":{"ideas":9},"stated":0},{"year":1991,"topics":{"ideas":14},"stated":0},{"year":1992,"topics":{"ideas":15},"stated":0},{"year":1993,"topics":{"ideas":21,"people":3},"stated":0},{"year":1994,"topics":{"ideas":18},"stated":0},{"year":1995,"topics":{"ideas":10,"people":1},"stated":0},{"year":1996,"topics":{"ideas":71},"stated":0},{"year":1997,"topics":{"ideas":17},"stated":0},{"year":1998,"topics":{"ideas":50},"stated":0},{"year":1999,"topics":{"ideas":31,"people":1,"institutions":1},"stated":0},{"year":2000,"topics":{"ideas":70},"stated":0},{"year":2001,"topics":{"ideas":52},"stated":0},{"year":2002,"topics":{"ideas":30},"stated":0},{"year":2003,"topics":{"ideas":9},"stated":0},{"year":2004,"topics":{"ideas":14,"people":3},"stated":0},{"year":2005,"topics":{"ideas":20,"people":1},"stated":0},{"year":2006,"topics":{"ideas":26,"people":1},"stated":0},{"year":2007,"topics":{"ideas":21},"stated":0},{"year":2008,"topics":{"ideas":65,"people":3,"institutions":1},"stated":0},{"year":2009,"topics":{"ideas":12,"people":1},"stated":0},{"year":2010,"topics":{"people":3,"ideas":13,"institutions":1,"governance":4},"stated":0},{"year":2011,"topics":{"people":3,"ideas":16,"institutions":2},"stated":0},{"year":2012,"topics":{"people":4,"ideas":19,"institutions":2},"stated":0},{"year":2013,"topics":{"ideas":45,"people":4,"institutions":2,"capital":1},"stated":0},{"year":2014,"topics":{"institutions":2,"ideas":57,"people":5},"stated":0},{"year":2015,"topics":{"people":23,"ideas":133,"institutions":3,"capital":1},"stated":0},{"year":2016,"topics":{"ideas":88,"people":2},"stated":0},{"year":2017,"topics":{"people":16,"institutions":2,"ideas":130,"governance":2},"stated":0},{"year":2018,"topics":{"people":9,"ideas":159,"institutions":8,"governance":1},"stated":0},{"year":2019,"topics":{"capital":1,"compute":1,"people":11,"governance":19,"ideas":175,"institutions":4},"stated":0},{"year":2020,"topics":{"people":6,"ideas":98,"institutions":1,"governance":2},"stated":0},{"year":2021,"topics":{"people":27,"ideas":177,"compute":1,"institutions":23,"governance":4,"capital":6},"stated":0},{"year":2022,"topics":{"people":15,"ideas":228,"institutions":6,"governance":3,"compute":2,"capital":1},"stated":0},{"year":2023,"topics":{"capital":14,"compute":7,"institutions":24,"people":54,"governance":179,"ideas":409},"stated":0},{"year":2024,"topics":{"capital":31,"compute":19,"governance":282,"people":103,"ideas":180,"institutions":32},"stated":1},{"year":2025,"topics":{"governance":548,"compute":69,"capital":61,"people":145,"institutions":26,"ideas":180},"stated":7},{"year":2026,"topics":{"governance":444,"capital":31,"compute":32,"institutions":23,"ideas":97,"people":139},"stated":19},{"year":2027,"topics":{},"stated":8},{"year":2028,"topics":{},"stated":6},{"year":2029,"topics":{},"stated":3},{"year":2030,"topics":{},"stated":3},{"year":2032,"topics":{},"stated":2},{"year":2035,"topics":{},"stated":2},{"year":2039,"topics":{},"stated":1},{"year":2042,"topics":{},"stated":1},{"year":2050,"topics":{},"stated":1}],"scheduled":[],"statedBy":[]},"collections":[{"target":{"kind":"propositions","id":"superintelligence"},"title":"Propositions about superintelligence, 1863–2022","claimIds":[],"records":[]},{"target":{"kind":"propositions","id":"risk-debate"},"title":"Arguments about catastrophic risk from advanced AI","claimIds":[],"records":[]},{"target":{"kind":"propositions","id":"yudkowsky-arguments"},"title":"Eliezer Yudkowsky’s arguments on common claims about AI, 1996–2026","claimIds":[],"records":[]},{"target":{"kind":"propositions","id":"machine-succession"},"title":"Machine succession, scale and acceleration: propositions in located texts, 1979–2026","claimIds":[],"records":[]},{"target":{"kind":"propositions","id":"economics-of-machine-intelligence"},"title":"Economics of machine intelligence","claimIds":[],"records":[]},{"target":{"kind":"propositions","id":"orbital-compute-arguments"},"title":"Arguments about compute in orbit","claimIds":[],"records":[]},{"target":{"kind":"propositions","id":"ai-bio-arguments"},"title":"Arguments about AI and biological risk","claimIds":[],"records":[]},{"target":{"kind":"propositions","id":"ai-in-science"},"title":"AI in science","claimIds":["aib-arg-p1-blundell-1987","aib-arg-p1-sternberg-1992","aib-arg-p1-deepmind-2020","aib-arg-p1-mullard-2021","aib-arg-p1-wong-2022","aib-arg-p1-arnold-2023","aib-arg-p1-terwilliger-2023","aib-arg-p1-lyu-2024","aib-arg-p2-bray-1990","aib-arg-p2-tomita-2001","aib-arg-p2-ma-2018","aib-arg-p2-bunne-2024","aib-arg-p2-roohani-2025","aib-arg-p2-ahlmann-eltze-2025","aib-arg-p3-berg-2013","aib-arg-p3-sumitomo-2020","aib-arg-p3-exscientia-2021","aib-arg-p3-jayatunga-2024","aib-arg-p3-xu-2025","aib-arg-p3-insilico-2026","aib-arg-p6-jayatunga-2024","aib-arg-p6-xu-2025","aib-arg-p4-huang-2016","aib-arg-p4-wang-2018","aib-arg-p4-anishchenko-2020","aib-arg-p4-watson-2023","aib-arg-p4-esm3-2024","aib-arg-p5-hood-galas-2003","aib-arg-p5-isomorphic-2021","aib-arg-p5-esm3-2024"],"records":[]},{"target":{"kind":"documents"},"title":"Frontier safety frameworks","claimIds":[]},{"target":{"kind":"compare","id":"frontier-safety-frameworks"},"title":"Compare frameworks","claimIds":[]},{"target":{"kind":"control","id":"openai"},"title":"OpenAI’s control structure, 2015–2026","claimIds":[]},{"target":{"kind":"control","id":"anthropic"},"title":"Anthropic’s control structure, 2021–2026","claimIds":[]},{"target":{"kind":"commitments"},"title":"External commitments and obligations","claimIds":[]},{"target":{"kind":"question","id":"frameworks-to-obligations"},"title":"Frameworks, commitments and legal obligations, 2023–2026","claimIds":[]},{"target":{"kind":"reading"},"title":"Founding and early leadership","claimIds":[]}]},"version":"15mccro"}